Nathan den Broeder

14PUBLICATIONS
22CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)BiomechanicsCancer therapy (excl. chemotherapy and radiation therapy)Soil chemistry and soil carbon sequestration (excl. carbon sequestration science)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 25, 2025
Long-Term Routine Laboratory Toxicity Monitoring of Immunomodulatory Drugs in Rheumatoid Arthritis : A Retrospective Cohort Study.

Evy Ulijn, Nathan den Broeder, Karen Bevers

|Aug 12, 2025
Continuation Versus Temporary Interruption of Immunomodulatory Agents During Infections in Patients With Inflammatory Rheumatic Diseases: A Randomized Controlled Trial.

Merel A A Opdam, Nathan den Broeder, Reinout van Crevel

|Jul 07, 2025
Disease Activity Score in 28 joints using C-reactive protein based remission state and still residual swollen joints: theoretically possible, but does it occur in the real world?

Psm Groenen, N den Broeder, Mhm Wientjes

|Jun 25, 2025
Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental study.

Ilse van Es, Johanna E Vriezekolk, Nathan den Broeder

|Jun 13, 2024
Effect of using the Simple Erosion Narrowing Score or Sharp/van der Heijde score on the power of rheumatoid arthritis clinical trials to detect differences in radiographic progression.

Nathan den Broeder, Thomas E Bolhuis, Noortje van Herwaarden

|Apr 10, 2024
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.

Nathan den Broeder, Lise Verhoef, Yaël A de Man

Pageof 3

Frequent Collaborators

4 joint publications

Alfons A den Broeder

2 joint publications

Celia Aj Michielsens

2 joint publications

Thomas E Bolhuis

2 joint publications

Mhm Wientjes